solifenacin succinate has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlering, TE; Liss, MA; Morales, B; Skarecky, D | 1 |
| Ahn, H; Choi, SK; Choo, MS; Huh, KO; Kim, J; Lee, SM; Park, S; Shim, M; Song, C | 1 |
2 trial(s) available for solifenacin succinate and Cancer of Prostate
| Article | Year |
|---|---|
Phase 1 clinical trial of Vesicare™ (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.
Topics: Aged; Humans; Male; Middle Aged; Muscarinic Antagonists; Pilot Projects; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quinuclidines; Robotic Surgical Procedures; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Incontinence | 2014 |
The therapeutic effect of solifenacin succinate on the recovery from voiding dysfunction after radical prostatectomy in men with clinically localized prostate cancer: a prospective, randomized, controlled study.
Topics: Adrenergic alpha-1 Receptor Agonists; Aged; Drug Therapy, Combination; Humans; Male; Midodrine; Muscarinic Antagonists; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quinuclidines; Recovery of Function; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Incontinence | 2015 |